Scholarlink

Purpose <p>Twist1 is a transcription factor that regulates embryonic development, stemness, and differentiation, and can also stimulate initiation of tumorigenesis in peripheral solid cancers. However, its role in central nervous system tumors, including medulloblastoma (MB), the main type of malignant brain cancer that afflicts children, remains poorly understood. Here, we examined expression of Twist1, and its potential significance in prognosis, in different histological variants and molecular subgroups of MB.</p> Methods <p>Gene expression data for <i>TWIST1</i> and corresponding overall survival (OS) of patients was analyzed in 612&#xa0;MB samples using a previously described dataset. A cross-sectional analysis of Twist1 protein content in 24&#xa0;MB tumor samples from patients was carried out by immunohistochemistry.</p> Results <p><i>TWIST1</i> transcript levels were higher in classic MB compared to desmoplastic tumors. Within samples with classic histology, higher <i>TWIST1</i> expression was associated with a longer OS. Tumors in the SHH subgroup had lower <i>TWIST1</i> expression compared to all other subgroups, and Group 4 showed lower expression than WNT tumors. In Group 4&#xa0;MB, higher <i>TWIST1</i> levels were associated with shorter OS, whereas patients with SHH tumors and higher <i>TWIST1</i> levels showed longer OS. Twist1 protein was detectable in part of classic and LCA MB tumors belonging to the SHH, WNT, or Group 3/4 subgroups.</p> Conclusion <p>We found opposite patterns of association between <i>TWST1</i> and patient survival in Group 4 and SHH MB subgroups. Our results highlight the importance of stratifying tumors by molecular subgroup and histological classification when exploring novel potential biomarkers and therapeutic targets in MB.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Opposite patterns of association of TWIST1 expression with patient survival in SHH and Group 4 medulloblastoma

  • 期刊论文

  • 发表日期：

    2025年9月11日

查看全文
  • Karina Munhoz de Paula Alves Coelho,
  • Matheus Dalmolin,
  • Francis Rossetti Pedack,
  • José Guilherme Pickler,
  • Camila Barbosa,
  • Julio Recalde,
  • Rodrigo Blasius,
  • Bruna Louise Silva,
  • Marcelo A. C. Fernandes,
  • Hercilio Fronza Junior,
  • Paulo Henrique Condeixa de França,
  • Rafael Roesler

摘要

Purpose

Twist1 is a transcription factor that regulates embryonic development, stemness, and differentiation, and can also stimulate initiation of tumorigenesis in peripheral solid cancers. However, its role in central nervous system tumors, including medulloblastoma (MB), the main type of malignant brain cancer that afflicts children, remains poorly understood. Here, we examined expression of Twist1, and its potential significance in prognosis, in different histological variants and molecular subgroups of MB.

Methods

Gene expression data for TWIST1 and corresponding overall survival (OS) of patients was analyzed in 612 MB samples using a previously described dataset. A cross-sectional analysis of Twist1 protein content in 24 MB tumor samples from patients was carried out by immunohistochemistry.

Results

TWIST1 transcript levels were higher in classic MB compared to desmoplastic tumors. Within samples with classic histology, higher TWIST1 expression was associated with a longer OS. Tumors in the SHH subgroup had lower TWIST1 expression compared to all other subgroups, and Group 4 showed lower expression than WNT tumors. In Group 4 MB, higher TWIST1 levels were associated with shorter OS, whereas patients with SHH tumors and higher TWIST1 levels showed longer OS. Twist1 protein was detectable in part of classic and LCA MB tumors belonging to the SHH, WNT, or Group 3/4 subgroups.

Conclusion

We found opposite patterns of association between TWST1 and patient survival in Group 4 and SHH MB subgroups. Our results highlight the importance of stratifying tumors by molecular subgroup and histological classification when exploring novel potential biomarkers and therapeutic targets in MB.